3 outlets·3 reports·over 20h
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
ThinkingNews Desk · how this was written
OpenAI researcher Miles Wang is departing the company to create an artificial-intelligence-driven drug-discovery startup. The venture is being discussed at a valuation of roughly two billion dollars, with plans to raise about two hundred million dollars in financing. The startup’s name has not yet been disclosed.
Written from all 3 reports below, not from any single one.
How it was reported
- TechCrunch·OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
- TechMeme·Sources: OpenAI researcher Miles Wang is leaving the company to launch an AI drug discovery startup, and is in talks to raise $200M at a $2B valuation (Marina Temkin/TechCrunch)
- The Next Web·An OpenAI researcher is leaving to build a $2bn AI drug startup that has no name yet
Related stories
- Sources: OpenAI is close to finalizing the first phase of its $100B round; its overall valuation, including the eventual funding, could exceed $850B (Bloomberg)3 outlets
- OpenAI will provide free AI models to select researchers3 outlets
- AI coding startup Cognition reportedly already in talks to raise at $40B valuation3 outlets
- OpenAI, not yet public, raises $3B from retail investors in monster $122B fund raise4 outlets